Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Replimune Inc.
- Target Recruit Count
- 340
- Registration Number
- NCT03767348
- Locations
- 🇺🇸
University of Birmingham Alabama, Birmingham, Alabama, United States
🇺🇸Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2024. All Rights Reserved by MedPath